SCHEMBL8596342

SCHEMBL8596342

CC(CN)Oc1ccccc1F

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
GAA P10253 2/20 0.50
LMNA P02545 3/20 0.43
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
HPGD P15428 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PKM P14618 1/20 0.38
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
FFAR1 O14842 1/20 0.36
TAAR1 Q96RJ0 4/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17366266 0.82 ALDH1A1 (0.47) ALDH1A1GAALMNAPPARGPPARA
SCHEMBL20269984 0.81 ALDH1A1 (0.46) ALDH1A1GAALMNAPPARGPPARA
SCHEMBL17366254 0.79 MCHR1 (0.48) ALDH1A1GAALMNAPPARGPPARA
SCHEMBL11024920 0.78 MTNR1A (0.54) ALDH1A1LMNAL3MBTL1TDP1TAAR1
SCHEMBL7412875 0.78 MTNR1A (0.54) ALDH1A1LMNAL3MBTL1TDP1TAAR1
SCHEMBL11022430 0.78 MTNR1A (0.54) ALDH1A1LMNAL3MBTL1TDP1TAAR1
SCHEMBL6318517 0.78 ALOX15 (0.49) LMNAHPGDL3MBTL1TP53SMN1; SMN2
SCHEMBL17459933 0.78 ALDH1A1 (0.54) ALDH1A1GAALMNAPPARGPPARA
SCHEMBL104729 0.77 ALDH1A1 (0.53) ALDH1A1GAALMNAPPARGPPARA
SCHEMBL17070600 0.77 ALDH1A1 (0.53) ALDH1A1GAALMNAPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180273528-A1 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LES LABORATOIRES SERVIER (FR) 2018-09-27 US disclosed
WO-1998033765-A1 FUNGICIDAL CARBOXAMIDES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-08-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180273528-A1 IMIDAZO[4,5-b]PYRIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM IDH2, CYP4B1, RB1 ALDH1A1 410/4885GAA 1495/4885LMNA 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.